Innoviva (INVA) Current Deferred Revenue (2016 - 2025)
Historic Current Deferred Revenue for Innoviva (INVA) over the last 13 years, with Q3 2025 value amounting to $13.6 million.
- Innoviva's Current Deferred Revenue rose 179274.76% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 179274.76%. This contributed to the annual value of $1.1 million for FY2024, which is 1182.46% down from last year.
- According to the latest figures from Q3 2025, Innoviva's Current Deferred Revenue is $13.6 million, which was up 179274.76% from $3.1 million recorded in Q2 2025.
- Innoviva's Current Deferred Revenue's 5-year high stood at $13.6 million during Q3 2025, with a 5-year trough of $717000.0 in Q3 2024.
- In the last 4 years, Innoviva's Current Deferred Revenue had a median value of $1.5 million in 2023 and averaged $2.7 million.
- As far as peak fluctuations go, Innoviva's Current Deferred Revenue plummeted by 7372.46% in 2024, and later surged by 179274.76% in 2025.
- Over the past 4 years, Innoviva's Current Deferred Revenue (Quarter) stood at $2.1 million in 2022, then plummeted by 39.02% to $1.3 million in 2023, then decreased by 11.82% to $1.1 million in 2024, then surged by 1105.24% to $13.6 million in 2025.
- Its Current Deferred Revenue was $13.6 million in Q3 2025, compared to $3.1 million in Q2 2025 and $1.0 million in Q1 2025.